Regulation & Policy (Pharma & Healthcare)


Publication Single User License (PDF) Price
Exenatide  - Comprehensive patent search

Exenatide - Comprehensive patent search

Date Published: Sep 16 2014

Exenatide - Comprehensive patent search Treatment of type 2 diabetes mellitus optionally in combination with Metformin and/or, a sulfonylurea or a thiazolidinedione; or as adjunctive therapy to basal insulin optionally in combination with Metformin and/or Pioglitazone; in adults who have not achieved adequate glycaemic control Amylin (Byetta, Bydureon); Bristol-Myers Squibb (Byetta, Bydureon)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$9,300.00
Eculizumab  - Comprehensive patent search

Eculizumab - Comprehensive patent search

Date Published: Sep 16 2014

Eculizumab - Comprehensive patent search Treatment of paroxysmal nocturnal haemoglobinuria, optionally in combination with a meningococcal vaccine; treatment of atypical haemolytic uraemic syndrome, optionally in combination with a meningococcal vaccine Alexion (Soliris)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$9,300.00
Abatacept  - Comprehensive patent search

Abatacept - Comprehensive patent search

Date Published: Sep 16 2014

Abatacept - Comprehensive patent search Treatment of adult rheumatoid arthritis, optionally in combination with DMARDs optionally other than TNF antagonists; Treatment of juvenile idiopathic arthritis, optionally in combination with Methotrexate; Treatment of juvenile rheumatoid arthritis Bristol Myers Squibb (Orencia)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$9,300.00
Aflibercept  - Comprehensive patent search

Aflibercept - Comprehensive patent search

Date Published: Sep 16 2014

Aflibercept - Comprehensive patent search Treatment of neovascular wet age-related macular degeneration; Treatment of macular edema following central retinal vein occlusion; Treatment of metastatic colorectal cancer that is resistant to or has progressed following an Oxaliplatin-containing regimen in combination with 5-Fluorouracil, Leucovorin and Irinotecan Regeneron (Eylea); Sanofi (Zaltrap, Lidaveg, Aflitiv); Bayer (Eylea)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$9,300.00
Denosumab  - Comprehensive patent search

Denosumab - Comprehensive patent search

Date Published: Sep 16 2014

Denosumab - Comprehensive patent search Treatment to increase bone mass in men with osteoporosis at high risk for fracture; prevention of skeletal related events in patients with bone metastases from solid tumours; treatment of giant cell tumour of bone or skeletally mature adolescents that is recurrent, or unresectable, or resectable but associated with severe morbidity; reduction of the risk of vertebral, non-vertebral and hip fractures; treatment of postmenopausal women with osteoporosis at high risk for fracture; treatment to increase bone mass in men with nonmetastatic prostate cancer

$9,300.00
Ledipasvir  - Comprehensive patent search

Ledipasvir - Comprehensive patent search

Date Published: Sep 16 2014

Ledipasvir - Comprehensive patent search Treatment of chronic HCV infection in combination with Sofosbuvir Gilead

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Aprepitant  - Comprehensive patent search

Aprepitant - Comprehensive patent search

Date Published: Sep 16 2014

Aprepitant - Comprehensive patent search Prevention of chemotherapy induced nausea and vomiting (CINV) in combination with Dexamethasone and other antiemetic agents including 5-HT3 antagonist; Prevention of postoperative nausea and vomiting (PONV) Merck (Emend)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Fosaprepitant  - Comprehensive patent search

Fosaprepitant - Comprehensive patent search

Date Published: Sep 16 2014

Fosaprepitant - Comprehensive patent search Prevention of chemotherapy induced nausea and vomiting (CINV) in combination with Dexamethasone and/or other antiemetic agents, preferably 5-HT3 antagonist Merck (Emend, Ivemend, Emend IV)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Paliperidone  - Comprehensive patent search

Paliperidone - Comprehensive patent search

Date Published: Sep 16 2014

Paliperidone - Comprehensive patent search Treatment of schizophrenia, optionally in combination with antidepressants and/or mood stabilisers, preferably lithium or Valproate Janssen (Invega, Invega Sustenna); Johnson & Johnson (Invega Sustenna)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Ticagrelor  - Comprehensive patent search

Ticagrelor - Comprehensive patent search

Date Published: Sep 16 2014

Ticagrelor - Comprehensive patent search Prevention of thrombotic events in a patient with acute coronary syndromes, optionally in combination with Aspirin AstraZeneca (Brilinta, Possia, Brilique)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Mipomersen  - Comprehensive patent search

Mipomersen - Comprehensive patent search

Date Published: Sep 16 2014

Mipomersen - Comprehensive patent search Reduction of low density lipoprotein-cholesterol, apolipoprotein B, total cholesterol, and non-high density lipoprotein-cholesterol in patients with homozygous familial hypercholesterolaemia, in combination with lipid-lowering drugs Genzyme (Kynamro)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Elvitegravir  - Comprehensive patent search

Elvitegravir - Comprehensive patent search

Date Published: Sep 16 2014

Elvitegravir - Comprehensive patent search Treatment of HIV-1 infection in combination with Cobicistat, Emtricitabine and Tenofovir disoproxil fumarate, or Ritonavir-boosted protease inhibitors or other antiretrovirals Gilead (Stribild); Gilead (Vitekta); Japan Tobacco (Vitekta)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Mirabegron  - Comprehensive patent search

Mirabegron - Comprehensive patent search

Date Published: Sep 16 2014

Mirabegron - Comprehensive patent search Treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency Astellas (Myrbetriq, Betmiga)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$6,201.00
Tolvaptan  - Comprehensive patent search

Tolvaptan - Comprehensive patent search

Date Published: Sep 16 2014

Tolvaptan - Comprehensive patent search Treatment of hypervolemic and euvolemic hyponatraemia secondary to syndrome of inappropriate antidiuretic-hormone secretion and congestive heart failure Otsuka Pharm (Samsca); Aspen (Samsca)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$6,200.00
Enzalutamide  - Comprehensive patent search

Enzalutamide - Comprehensive patent search

Date Published: Sep 16 2014

Enzalutamide - Comprehensive patent search Treatment of metastatic castration-resistant prostate cancer Medivation (MDV3100); Astellas Pharma (Xtandi)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$6,200.00
The Politics of Pharma - Washington, States and the Courts Impact on the Industry

The Politics of Pharma - Washington, States and the Courts Impact on the Industry

Date Published: Apr 15 2013

The Politics of Pharma - Washington, States and the Courts Impact on the Industry

Summary

Politics have a greater direct effect on the pharmaceutical industry than almost any other in the US, and correspondingly, pharma makes considerable investments in election campaigns. The November elections kept the face of Washington the same, with the re-election of President Obama, Democratic control of the Senate and Republican control of the House. However, the outcome of the elections will still impact the industry in a variety of ways.

$3,900.00
Pharmaceutical Pricing and Reimbursement - Adoption of Health Technology Assessments (HTA) Optimizes Drug Pricing and Accelerates Reimbursement Decision-Making

Pharmaceutical Pricing and Reimbursement - Adoption of Health Technology Assessments (HTA) Optimizes Drug Pricing and Accelerates Reimbursement Decision-Making

Date Published: Sep 1 2012
$3,500.00
Respiratory Disorders Therapeutics Market to 2017

Respiratory Disorders Therapeutics Market to 2017 - Novel Pipeline Molecules such as VX-770 and pirfenidone May Offset Negative Effect of Patent Expiries

Date Published: Sep 1 2011
$3,500.00
Electronic Medical Records Market to 2017

Electronic Medical Records Market to 2017 - Government Financial Incentives and Benefits in terms of Costs and Quality of Healthcare Drive Adoption among Physicians and Hospitals

Date Published: Mar 31 2012

Electronic Medical Records Market to 2017 - Government Financial Incentives and Benefits in terms of Costs and Quality of Healthcare Drive Adoption among Physicians and Hospitals

 

Summary

 
$3,500.00
Drug Recalls and Warning Letters

Drug Recalls and Warning Letters - Increasing Numbers Caused by Manufacturing Errors and Regulatory Non-compliance Issues

Date Published: May 7 2011

Drug Recalls and Warning Letters - Increasing Numbers Caused by Manufacturing Errors and Regulatory Non-compliance Issues

 

Summary

 
$3,500.00

Pages

Shopping cart

0 Items $0.00
Market Research Special Offers
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data